康弘药业(002773.SZ)：KHN707片获准开展用于失眠症临床试验

Core Viewpoint - Kanghong Pharmaceutical has received approval from the National Medical Products Administration for clinical trials of KHN707 tablets, which are intended for the treatment of insomnia [1] Group 1 - The company announced the receipt of the clinical trial approval notice [1] - The drug KHN707 is specifically aimed at treating insomnia [1]